Accueil   Diary - News   All news Indicia Production announces acquisition of Bio-Steril

Indicia Production announces acquisition of Bio-Steril

 

Allows Indicia to extend manufacturing capabilities and open new market areas

 

Saint-Genis-l’Argentière, France, September 17, 2019 – Indicia Production, a Contract Manufacturing Organization (CMO) specializing in the manufacture of ready touse microbiological media and sterile pharmaceutical ingredients, today announces the acquisition of Bio-Steril, a company that specializes in the formulation and Fill & Finish of medical devices for cosmetic and medical uses. The financial terms of the transaction have not been disclosed. 

 


This allows Indicia to extend its manufacturing capabilities and open new market areas, such as dermo-aesthetics, ophthalmology and rheumatology. It also means that Indicia can now provide a highly specialized manufacturing area dedicated to the filling of dermal filler in syringes.

 

 

Read the press release

 

 

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree